Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Scholar Rock Holding Corp (SRRK)

Scholar Rock Holding Corp (SRRK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,949,160
  • Shares Outstanding, K 114,883
  • Annual Sales, $ 0 K
  • Annual Income, $ -377,940 K
  • EBIT $ -385 M
  • EBITDA $ -387 M
  • 60-Month Beta 0.70
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 17.70

Options Overview Details

View History
  • Implied Volatility 63.25% (-13.46%)
  • Historical Volatility 70.85%
  • IV Percentile 24%
  • IV Rank 14.39%
  • IV High 152.07% on 09/22/25
  • IV Low 48.31% on 07/21/25
  • Expected Move (DTE 17) 4.97 (10.11%)
  • Put/Call Vol Ratio 0.24
  • Today's Volume 658
  • Volume Avg (30-Day) 557
  • Put/Call OI Ratio 1.08
  • Today's Open Interest 14,747
  • Open Int (30-Day) 16,100
  • Expected Range 44.19 to 54.13

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.83
  • Number of Estimates 7
  • High Estimate $-0.75
  • Low Estimate $-0.90
  • Prior Year $-0.67
  • Growth Rate Est. (year over year) -23.88%

Price Performance

See More
Period Period Low Period High Performance
1-Month
38.75 +26.86%
on 03/19/26
50.50 -2.65%
on 03/31/26
+4.89 (+11.05%)
since 02/27/26
3-Month
38.75 +26.86%
on 03/19/26
50.50 -2.65%
on 03/31/26
+3.49 (+7.64%)
since 12/26/25
52-Week
22.71 +116.47%
on 04/09/25
50.50 -2.65%
on 03/31/26
+16.32 (+49.70%)
since 03/28/25

Most Recent Stories

More News
Stocks Surge on Signs the US and Iran Seek to End War

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed up +2.91%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +2.49%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +3.43%. June E-mini...

ALK : 36.78 (+7.58%)
GOOGL : 287.56 (+5.14%)
AAPL : 253.79 (+2.90%)
SNDK : 635.34 (+10.98%)
ADI : 318.14 (+4.96%)
CNTA : 39.72 (+44.02%)
OXY : 65.00 (-1.87%)
TSLA : 371.75 (+4.64%)
STX : 391.76 (+8.09%)
WDC : 270.49 (+7.48%)
SPY : 650.34 (+2.91%)
META : 572.13 (+6.67%)
Stocks Climb on Hopes for an End to Iran War

The S&P 500 Index ($SPX ) (SPY ) today is up +1.02%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.67%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.10%. June E-mini S&P futures (ESM26...

GOOGL : 287.56 (+5.14%)
AMAT : 341.79 (+5.78%)
AAPL : 253.79 (+2.90%)
AVGO : 309.51 (+5.49%)
SNDK : 635.34 (+10.98%)
DHI : 137.22 (+3.54%)
BLDR : 82.33 (+4.41%)
CNTA : 39.72 (+44.02%)
$IUXX : 23,740.19 (+3.43%)
ASML : 1,320.83 (+5.33%)
ZNM26 : 111-020 (+0.01%)
MSFT : 370.17 (+3.12%)
Stocks Rally as President Trump Considers Ending Iran War

The S&P 500 Index ($SPX ) (SPY ) today is up +1.33%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +1.10%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.45%. June E-mini S&P futures (ESM26...

GOOGL : 287.56 (+5.14%)
AMAT : 341.79 (+5.78%)
AAPL : 253.79 (+2.90%)
DHI : 137.22 (+3.54%)
BLDR : 82.33 (+4.41%)
CNTA : 39.72 (+44.02%)
$IUXX : 23,740.19 (+3.43%)
ASML : 1,320.83 (+5.33%)
ZNM26 : 111-020 (+0.01%)
MSFT : 370.17 (+3.12%)
KBH : 51.75 (+2.45%)
TSLA : 371.75 (+4.64%)
Scholar Rock Resubmits Biologics License Application (BLA) to FDA for Apitegromab for Treatment of Children and Adults with Spinal Muscular Atrophy (SMA)

Apitegromab BLA resubmission includes Catalent Indiana LLC (part of Novo Nordisk) and second U.S.-based fill-finish facility, aligned with FDA guidance from March 3, 2026 Type C meeting ...

SRRK : 49.16 (+14.11%)
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 60,655 shares of its common stock to five newly hired employees,...

SRRK : 49.16 (+14.11%)
Scholar Rock Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights

Apitegromab Biologics License Application (BLA) resubmission and U.S. launch, following FDA approval, are anticipated in 2026 for the treatment of children and adults with spinal muscular atrophy (SMA)...

OWL : 9.13 (+0.66%)
SRRK : 49.16 (+14.11%)
Scholar Rock to Present at Upcoming Investor Conferences

Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company dedicated to dramatically improving the lives of children and adults with spinal muscular atrophy (SMA) and additional rare, severe, and...

SRRK : 49.16 (+14.11%)
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the Company granted inducement equity awards covering an aggregate of 114,668 shares of its common stock to seven newly hired employees,...

SRRK : 49.16 (+14.11%)
Scholar Rock to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Scholar Rock (NASDAQ: SRRK) today announced that it will report fourth quarter and full year 2025 financial results on Tuesday, March 3, 2026, before the financial markets open. The Company...

SRRK : 49.16 (+14.11%)
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Scholar Rock (NASDAQ: SRRK; the “Company”) today announced that the company granted inducement equity awards covering an aggregate of 35,200 shares of its common stock to two newly hired employees,...

SRRK : 49.16 (+14.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 50%. The market is indicating support for a bullish trend.

See More Share

Business Summary

Scholar Rock Holding Corporation is a biopharmaceutical company. It focused on the discovery and development of medicines for treatment of serious diseases. The company's product candidate includes SRK-015 and BMP6 which is in pre-clinical stage. Scholar Rock Holding Corporation is based in Cambridge,...

See More

Key Turning Points

3rd Resistance Point 54.73
2nd Resistance Point 52.62
1st Resistance Point 50.89
Last Price 49.16
1st Support Level 47.04
2nd Support Level 44.93
3rd Support Level 43.20

See More

52-Week High 50.50
Last Price 49.16
Fibonacci 61.8% 39.88
Fibonacci 50% 36.60
Fibonacci 38.2% 33.33
52-Week Low 22.71

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.